Subcutaneous testosterone: An effective delivery mechanism for masculinizing young transgender men

LGBT Health

Volumn 1, Issue 3, 2014, Pages 165-167

  Olson, Johanna ^a,b   Schrager, Sheree M ^a   Clark, Leslie F ^a,b   Dunlap, Shannon L ^c   Belzer, Marvin ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

masculinization; subcutaneous testosterone; transgender men; transgender youth

Indexed keywords

EID: 84969218037     PISSN: 23258292     EISSN: 23258306     Source Type: Journal    
DOI: 10.1089/lgbt.2014.0018     Document Type: Article

References (8)

1. Grossman AH, D'Augelli AR: Transgender youth and lifethreatening behaviors. Suicide Life Threat Behav 2007;37: 527-537.
2. Coolhart D, Baker A, Farmer S, Malaney M, Shipman D: Therapy with transsexual youth and their families: A clinical tool for assessing youth's readiness for gender transition. J Marital Fam Ther 2012;39:223-243.
3. Mueller A, Kiesewetter F, Binder H, Beckmann MW, Dittrich R: Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals. J Clin Endocrinol Metab 2007;92:3470-3475.
4. Wright E: Hypogonadism: Treatment, side effects and monitoring. University of Tennessee Advanced Studies in Pharmacy 3;2007:149-156.
5. Jacobeit JW,Gooren LJ, Schulte HM: Long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals. J Sex Med 2007;4:1479-1484.
6. Zacharin MR, Warne GL: Treatment of hypogonadal adolescent boys with long acting subcutaneous testosterone pellets. Arch Dis Child 1997;76:495-499.
7. Al-Futaisi AM, Al-Zakwani IS, Almahrezi AM, Morris D: Subcutaneous administration of testosterone. A pilot study report. Saudi Med J 2006;27:1843-1846.
8. Seftel A: Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents. Int J Impot Res 2007;19:2-24.